KLG Stock +78.58% In 3 Months Since We Picked KLG Stock +78.58% In 3 Months Since We Picked Unlock All Top Buy Picks
NASDAQ:ALDR
Delisted

Alder BioPharmaceuticals Stock Price (Quote)

NASDAQ Stock Exchange
Open Broker Account
$18.88
+0 (+0%)
At Close: Apr 15, 2020
Forecast Insider Trading Signals Historical Prices Predictions Profile

Range Low Price High Price Comment
30 days $18.88 $18.88 Wednesday, 15th Apr 2020 ALDR stock ended at $18.88. During the day the stock fluctuated 0% from a day low at $18.88 to a day high of $18.88.
90 days $18.88 $18.88
52 weeks $8.39 $19.12

Historical Alder BioPharmaceuticals prices

Date Open High Low Close Volume
Oct 15, 2019 $18.93 $18.93 $18.87 $18.88 3 290 731
Oct 14, 2019 $18.87 $18.92 $18.86 $18.92 1 899 106
Oct 11, 2019 $18.92 $18.92 $18.85 $18.87 3 396 856
Oct 10, 2019 $18.90 $18.92 $18.86 $18.88 3 027 317
Oct 09, 2019 $18.86 $18.94 $18.85 $18.93 3 977 656
Oct 08, 2019 $18.88 $18.90 $18.85 $18.86 7 924 722
Oct 07, 2019 $18.87 $18.99 $18.87 $18.91 2 632 185
Oct 04, 2019 $18.85 $18.93 $18.83 $18.90 4 537 816
Oct 03, 2019 $18.89 $18.89 $18.83 $18.87 4 816 122
Oct 02, 2019 $18.79 $18.87 $18.79 $18.86 2 865 005
Oct 01, 2019 $18.88 $18.90 $18.81 $18.84 3 161 378
Sep 30, 2019 $18.73 $18.95 $18.73 $18.86 4 750 936
Sep 27, 2019 $18.81 $18.84 $18.75 $18.78 3 031 351
Sep 26, 2019 $18.75 $18.83 $18.74 $18.81 3 201 965
Sep 25, 2019 $18.78 $18.83 $18.72 $18.76 2 071 725
Sep 24, 2019 $18.66 $18.82 $18.65 $18.78 3 057 050
Sep 23, 2019 $18.64 $18.70 $18.60 $18.63 5 451 001
Sep 20, 2019 $18.65 $18.72 $18.60 $18.64 7 129 125
Sep 19, 2019 $18.75 $18.78 $18.65 $18.66 6 325 310
Sep 18, 2019 $18.67 $18.90 $18.66 $18.71 9 484 343
Sep 17, 2019 $18.50 $18.82 $18.50 $18.70 14 652 245
Sep 16, 2019 $18.48 $18.88 $18.34 $18.50 49 580 986
Sep 13, 2019 $9.75 $10.14 $9.72 $10.06 685 715
Sep 12, 2019 $9.81 $9.84 $9.57 $9.74 464 464
Sep 11, 2019 $9.23 $9.77 $9.12 $9.75 794 531
Click to get the best stock tips daily for free!

About Alder BioPharmaceuticals

Alder BioPharmaceuticals Alder BioPharmaceuticals, Inc., a clinical-stage biopharmaceutical company, discovers, develops, and commercializes therapeutic antibodies in the United States and Australia. The company’s lead product candidate ALD403, an antibody, which is in Phase II clinical trial to target calcitonin gene-related peptide for the prevention of migraine. It also develops ALD1613, which is in preclinical stage to treat patients with congenital adrenal hyperpla... ALDR Profile

Golden Star

Ticker Date Change Price
DHT Apr 24 2.04% $11.28
MLI Apr 19 9.66% $52.28
LPLA Apr 19 1.42% $262.59
DOOR Apr 18 0.167% $131.39
LNG Apr 17 1.49% $156.81
FCN Apr 16 1.80% $207.62
ELV Apr 16 5.97% $506.97
AKR Apr 05 4.78% $16.53
ITCI Apr 05 7.04% $68.44
VSTS Apr 04 0.425% $18.82
Unlock

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT